The Role of Arachidonic Acid Metabolism in Myocardial Ischemia–Reperfusion Injury

[1]  Daniel J. C. Herr,et al.  Regulation of metabolism by mitochondrial enzyme acetylation in cardiac ischemia-reperfusion injury. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[2]  M. Schwartzman,et al.  20‐HETE in the regulation of vascular and cardiac function , 2018, Pharmacology & therapeutics.

[3]  Daniel P Jones,et al.  Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders , 2018, Biology.

[4]  Xiangmei Chen,et al.  Ophiopogonin D alleviates cardiac hypertrophy in rat by upregulating CYP2J3 in vitro and suppressing inflammation in vivo. , 2018, Biochemical and biophysical research communications.

[5]  Yucheng Jiao,et al.  Propionibacterium acnes Induces Intervertebral Disc Degeneration by Promoting iNOS/NO and COX-2/PGE2 Activation via the ROS-Dependent NF-κB Pathway , 2018, Oxidative medicine and cellular longevity.

[6]  J. W. Park,et al.  Posttranslational regulation of CYP2J2 by nitric oxide , 2018, Free radical biology & medicine.

[7]  N. Soliman,et al.  Vildagliptin Recruits Regulatory T Cells in Patients Undergoing Primary Percutaneous Coronary Intervention , 2018, Immunological investigations.

[8]  D. Lio,et al.  A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status? , 2018, Oxidative medicine and cellular longevity.

[9]  S. Cadenas.  ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. , 2018, Free radical biology & medicine.

[10]  A. Ibrahim,et al.  Role of endoplasmic reticulum stress in 12/15-lipoxygenase-induced retinal microvascular dysfunction in a mouse model of diabetic retinopathy , 2018, Diabetologia.

[11]  J. Martel-Pelletier,et al.  Deletion of 12/15-lipoxygenase accelerates the development of aging-associated and instability-induced osteoarthritis. , 2017, Osteoarthritis and cartilage.

[12]  E. Springman,et al.  Recent advances in clinical development of leukotriene B4 pathway drugs. , 2017, Seminars in immunology.

[13]  M. Holinstat,et al.  Who is the real 12-HETrE? , 2017, Prostaglandins & other lipid mediators.

[14]  L. Gan,et al.  Soluble epoxide hydrolase activation by S-nitrosation contributes to cardiac ischemia-reperfusion injury. , 2017, Journal of molecular and cellular cardiology.

[15]  C. Palmer,et al.  Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea‐induced hypoglycaemia: A GoDARTS Study , 2017, Diabetes, obesity & metabolism.

[16]  D. Dalvie,et al.  Glucuronides as Potential Anionic Substrates of Human Cytochrome P450 2C8 (CYP2C8). , 2017, Journal of medicinal chemistry.

[17]  J. Falck,et al.  Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction. , 2017, American journal of physiology. Heart and circulatory physiology.

[18]  C. Cannon,et al.  Acute myocardial infarction , 2017, The Lancet.

[19]  R. Eckenhoff,et al.  Intravenous anesthetic propofol binds to 5‐lipoxygenase and attenuates leukotriene B4 production , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Tianying Wang,et al.  Coxsackievirus B3 induces the formation of autophagosomes in cardiac fibroblasts both in vitro and in vivo. , 2016, Experimental cell research.

[21]  P. Vemuri,et al.  Intracellular zinc status influences cisplatin-induced endothelial permeability through modulation of PKCα, NF-κB and ICAM-1 expression. , 2016, European journal of pharmacology.

[22]  N. Tribulova,et al.  Disordered myocardial Ca(2+) homeostasis results in substructural alterations that may promote occurrence of malignant arrhythmias. , 2016, Physiological research.

[23]  Barbara Sitek,et al.  Simultaneous quantification of PGI2 and TXA2 metabolites in plasma and urine in NO-deficient mice by a novel UHPLC/MS/MS method. , 2016, Journal of pharmaceutical and biomedical analysis.

[24]  Chuen-Mao Yang,et al.  AdipoR-increased intracellular ROS promotes cPLA2 and COX-2 expressions via activation of PKC and p300 in adiponectin-stimulated human alveolar type II cells. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[25]  Kui Yang,et al.  Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A2γ (iPLA2γ) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size * , 2016, The Journal of Biological Chemistry.

[26]  Yundai Chen,et al.  Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. , 2016, Free radical biology & medicine.

[27]  D. McKay,et al.  Bidirectional crosstalk via IL‐6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti‐inflammatory phenotype in both cells , 2016, British journal of pharmacology.

[28]  J. Scholey,et al.  Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. , 2016, Journal of molecular and cellular cardiology.

[29]  H. Zhang,et al.  Remote Ischemic Postconditioning Ameliorates the Mesenchymal Stem Cells Engraftment in Reperfused Myocardium , 2016, PloS one.

[30]  J. Strosznajder,et al.  The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease , 2015, Neurochemical Research.

[31]  Hyung Gyun Kim,et al.  Endosulfan induces COX-2 expression via NADPH oxidase and the ROS, MAPK, and Akt pathways , 2015, Archives of Toxicology.

[32]  K. Macleod,et al.  Tumor suppressor functions of BNIP3 and mitophagy , 2015, Autophagy.

[33]  F. Mach,et al.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2. , 2015, Antioxidants & redox signaling.

[34]  Shan-shan Geng,et al.  Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway , 2015, Inflammation.

[35]  Xiaojing Tang,et al.  Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication. , 2015, Current drug metabolism.

[36]  Edward T Chouchani,et al.  Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS , 2014, Nature.

[37]  Hong Jiang,et al.  Necrostatin‐1 inhibits Hmgb1‐IL‐23/IL‐17 pathway and attenuates cardiac ischemia reperfusion injury , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[38]  Y. Horio,et al.  Translocation of Glycogen Synthase Kinase-3β (GSK-3β), a Trigger of Permeability Transition, Is Kinase Activity-dependent and Mediated by Interaction with Voltage-dependent Anion Channel 2 (VDAC2)* , 2014, The Journal of Biological Chemistry.

[39]  E. Tremoli,et al.  Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  L. Xiong,et al.  TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury , 2014, Basic Research in Cardiology.

[41]  N. Khaper,et al.  Oxidative Stress and Antioxidant Strategies in Cardiovascular Disease , 2014, Oxidative medicine and cellular longevity.

[42]  G. Valacchi,et al.  Redox Imbalance and Morphological Changes in Skin Fibroblasts in Typical Rett Syndrome , 2014, Oxidative medicine and cellular longevity.

[43]  J. Falck,et al.  20-HETE Regulates the Angiogenic Functions of Human Endothelial Progenitor Cells and Contributes to Angiogenesis In Vivo , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[44]  G. Siest,et al.  Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids , 2014, Drug metabolism reviews.

[45]  T. Woodruff,et al.  Neutrophils—A Key Component of Ischemia-Reperfusion Injury , 2013, Shock.

[46]  S. Paruchuri,et al.  Cysteinyl leukotrienes regulate endothelial cell inflammatory and proliferative signals through CysLT2 and CysLT1 receptors , 2013, Scientific Reports.

[47]  L. Faccioli,et al.  Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia–reperfusion-mediated tissue injury , 2013, Journal of cellular and molecular medicine.

[48]  Qifeng Zhao,et al.  LipoxinA4 attenuates myocardial ischemia reperfusion injury via a mechanism related to downregulation of GRP-78 and caspase-12 in rats , 2013, Heart and Vessels.

[49]  Peter Scarborough,et al.  Cardiovascular disease in Europe: epidemiological update. , 2014, European heart journal.

[50]  Mei-qi Zhang,et al.  Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway , 2013, Acta Pharmacologica Sinica.

[51]  M. Taniguchi,et al.  Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice. , 2013, Journal of molecular and cellular cardiology.

[52]  Qifeng Zhao,et al.  Lipoxin A4 Preconditioning and Postconditioning Protect Myocardial Ischemia/Reperfusion Injury in Rats , 2013, Mediators of inflammation.

[53]  G. Christensen,et al.  The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. , 2013, Cardiovascular research.

[54]  Chengwen Sun,et al.  20-Hydroxyeicosatetraenoic acid mediates isolated heart ischemia/reperfusion injury by increasing NADPH oxidase-derived reactive oxygen species production. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[55]  Xianlong Zhou,et al.  Effect of Lipoxin A4 on Myocardial Ischemia Reperfusion Injury Following Cardiac Arrest in a Rabbit Model , 2013, Inflammation.

[56]  A. Sheikh,et al.  Erratum to “NF-κB Signaling in the Brain of Autistic Subjects” , 2013, Mediators of Inflammation.

[57]  Teruaki Wajima,et al.  Neutrophil TRPM2 channels are implicated in the exacerbation of myocardial ischaemia/reperfusion injury. , 2013, Cardiovascular research.

[58]  T. Nakayama,et al.  A Novel Polymorphism of the CYP4A11 Gene is Associated With Coronary Artery Disease , 2013, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[59]  Y. Li,et al.  Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2. , 2012, Bioscience trends.

[60]  J. Inserte,et al.  Contribution of calpains to myocardial ischaemia/reperfusion injury. , 2012, Cardiovascular research.

[61]  A. Rodríguez-Sinovas,et al.  Calcium-mediated cell death during myocardial reperfusion. , 2012, Cardiovascular research.

[62]  R. Kloner,et al.  An apoptosis signal‐regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia‐reperfusion model , 2012, Journal of cardiovascular pharmacology.

[63]  Lei Xiao,et al.  Silencing of the integrin-linked kinase gene induces the apoptosis in ovarian carcinoma , 2012, Journal of receptor and signal transduction research.

[64]  Jing Yuan,et al.  Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. , 2012, Journal of the American College of Cardiology.

[65]  Chengwen Sun,et al.  20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways. , 2011, Journal of cardiovascular pharmacology.

[66]  Peter Carmeliet,et al.  Hypoxia and inflammation. , 2011, The New England journal of medicine.

[67]  G. Dorn,et al.  Receptor-Independent Cardiac Protein Kinase C&agr; Activation by Calpain-Mediated Truncation of Regulatory Domains , 2010, Circulation research.

[68]  G. Pierce,et al.  Reduced expression of the Na+/Ca2+ exchanger in adult cardiomyocytes via adenovirally delivered shRNA results in resistance to simulated ischemic injury. , 2010, American journal of physiology. Heart and circulatory physiology.

[69]  Craig R. Lee,et al.  Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. , 2010, Journal of molecular and cellular cardiology.

[70]  J. Iliff,et al.  Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. , 2008, American journal of physiology. Heart and circulatory physiology.

[71]  B. Lucchesi,et al.  Estrogen Protects the Heart From Ischemia-Reperfusion Injury via COX-2-Derived PGI2 , 2008, Journal of cardiovascular pharmacology.

[72]  Jing-Jun Zhou,et al.  Diastolic Ca2+ overload caused by Na+/Ca2+ exchanger during the first minutes of reperfusion results in continued myocardial stunning. , 2007, European journal of pharmacology.

[73]  S. Felix,et al.  COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia. , 2007, American journal of physiology. Heart and circulatory physiology.

[74]  G. Ertl,et al.  Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice. , 2007, European journal of pharmacology.

[75]  Yaqin Xu,et al.  Myocardial Infarct–Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes , 2006, Circulation.

[76]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[77]  J. Falck,et al.  Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel. , 2004, Journal of molecular and cellular cardiology.

[78]  J. Foley,et al.  Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway , 2004, Circulation research.

[79]  S. Karpatkin,et al.  Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. , 2004, The Journal of clinical investigation.

[80]  M. Yeager,et al.  Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R. Busse,et al.  Inhibition of Cytochrome P450 2C9 Improves Endothelium-Dependent, Nitric Oxide–Mediated Vasodilatation in Patients With Coronary Artery Disease , 2004, Circulation.

[82]  R. Bolli,et al.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. , 2002, Cardiovascular research.

[83]  S. Narumiya,et al.  Roles of Prostaglandin I2 and Thromboxane A2 in Cardiac Ischemia-Reperfusion Injury: A Study Using Mice Lacking Their Respective Receptors , 2001, Circulation.

[84]  Jilly F. Evans,et al.  Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.

[85]  H. Jacobson,et al.  Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. , 1993, The Journal of biological chemistry.

[86]  M. Karmazyn,et al.  Effects of epoxyeicosatrienoic acids on isolated hearts and ventricular myocytes. , 1993, The American journal of physiology.

[87]  M. Schork,et al.  Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog , 1983, Circulation.

[88]  S. Emani,et al.  Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion Injury. , 2017, Advances in experimental medicine and biology.

[89]  Xiang Zhu,et al.  MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress. , 2017, Current neurovascular research.

[90]  A. Ibrahim,et al.  Acute myocardial infarction. , 2014, Critical care clinics.

[91]  P. Scarborough,et al.  Cardiovascular disease in Europe 2014: epidemiological update. , 2014, European heart journal.